Diminishing morbidity with the increased use of sentinel node biopsy in breast carcinoma

American Journal of Surgery

Volumn 200, Issue 3, 2010, Pages 374-377

  Bafford, Andrea ^a   Gadd, Michele ^b   Gu, Xiangmei ^a   Lipsitz, Stuart ^a   Golshan, Mehra ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Breast cancer; Complications; Sentinel node biopsy

Indexed keywords

ADULT; AGED; ARTICLE; ASPIRATION; AXILLARY LYMPH NODE; BRACHIAL PLEXUS INJURY; BREAST CARCINOMA; CANCER PATIENT; CANCER STAGING; CELLULITIS; DEEP VEIN THROMBOSIS; FEMALE; HEMATOMA; HUMAN; INCIDENCE; LUNG EMBOLISM; LYMPH NODE DISSECTION; LYMPHOCELE; MAJOR CLINICAL STUDY; MORBIDITY; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RANGE OF MOTION; RETROSPECTIVE STUDY; SENTINEL LYMPH NODE BIOPSY; WOUND DEHISCENCE; WOUND INFECTION;

AXILLA; BREAST NEOPLASMS; FEMALE; HUMANS; INCIDENCE; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MIDDLE AGED; NEOPLASM STAGING; POSTOPERATIVE COMPLICATIONS; RETROSPECTIVE STUDIES; SENTINEL LYMPH NODE BIOPSY;

EID: 77956187359     PISSN: 00029610     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjsurg.2009.10.012     Document Type: Article

References (19)

1. M.A. Warmuth, G. Bowen, and L.R. Prosnitz Complications of axillary lymph node dissection for carcinoma of the breast: a report based on a patient survey Cancer 83 1998 1362 1368
2. D.F. Roses, A.D. Brooks, and M.N. Harris Complications of level I and II axillary dissection in the treatment o carcinoma of the breast Ann Surg 230 1999 194 201
3. D.L. Morton, D.R. Wen, and J.H. Wong Technical details of intraoperative lymphatic mapping for early stage melanoma Arch Surg 127 1992 392 399
4. A.E. Giuliano, D.M. Kirgan, and J.M. Guenther Lymphatic mapping and sentinel lymphadenectomy for breast cancer Ann Surg 220 1994 391 401
5. D.N. Krag, S. Harlow, and D. Weaver Radiolabeled sentinel node biopsy: collaborative trial with the National Cancer Institute World J Surg 25 2001 823 828
6. I. Langer, U. Guller, and G. Berclaz Morbidity of sentinel lymph node biopsy (SLN) alone versus SLN and completion axillary lymph node dissection after breast cancer surgery Ann Surg 245 2007 452 461
7. U. Veronesi, G. Paganelli, and G. Viale A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer N Engl J Med 349 2003 546 553
8. A.D. Purushotham, S. Upponi, and M.B. Klevesath Morbidity after sentinel lymph node biopsy in primary breast cancer: results from a randomized controlled trial J Clin Oncol 23 2005 4312 4321
9. R.E. Mansel, L. Fallowfield, and M. Kissin Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: the ALMANAC trial J Natl Cancer Inst 98 2006 599 609
10. R. Crane-Okada, R.A. Wascher, and D. Elashoff Long-term morbidity of sentinel node biopsy versus complete axillary dissection for unilateral breast cancer Ann Surg Oncol 15 2008 1996 2005
11. P. Del Bianco, G. Zavagno, and P. Burelli Morbidity comparison of sentinel lymph node biopsy versus conventional axillary lymph node dissection for breast cancer patients: results of the setinella-GIVOM Italian randomized clinical trial EJSO 34 2007 508 513
12. P. Schrenk, R. Rieger, and A. Shamiyeh Morbidity following sentinel lymph node biopsy versus axillary lymph node dissection for patients with breast carcinoma Cancer 88 2000 608 614
13. L.M. Sclafani, and R.H. Baron Sentinel lymph node biopsy and axillary dissection: added morbidity of the arm, shoulder and chest wall after mastectomy and reconstruction Cancer J 14 2008 216 222
14. G. Gill SNAC Trial Group of the Royal Australasian College of Surgeons (RACS) and NHMRC Clinical Trials Centre Sentinel-lymph-node-based management or routine axillary clearance? One-year outcomes of sentinel node biopsy versus axillary clearance (SNAC): a randomized controlled surgical trial Ann Surg Oncol 16 2009 266 275
15. J.A. Olson Jr, L.M. McCall, and P. Beitsch Impact of immediate versus delayed axillary node dissection on surgical outcomes in breast cancer patients with positive sentinel nodes: results from American College of Surgeons Oncology Group trials Z0010 and Z0011 J Clin Oncol 26 2008 3530 3535
16. A. Goyal, R.G. Newcombe, and A. Chhabra Morbidity in breast cancer patients with sentinel node metastases undergoing delayed axillary lymph node dissection (ALND) compared with immediate ALND Ann Surg Oncol 15 2008 262 267
17. D.N. Krag, J.A. Stewart, and T.B. Julian Technical outcomes of sentinel-lymph-node resection and conventional axillary-lymph-node dissection in patients with clinically node-negative breast cancer: results from the NSABP B-32 randomised phase III trial Lancet Oncol 8 2007 881 888
18. K.M. McMasters, T.M. Tuttle, and D.J. Carlson Sentinel lymph node biopsy for breast cancer: a suitable alternative to routine axillary dissection in multi-institutional practice when optimal technique is used J Clin Oncol 18 2000 2560 2566
19. L.G. Wilke, L.M. McCall, and K.E. Posther Surgical complications associated with sentinel lymph node biopsy: results from a prospective international cooperative group trial Ann Surg Oncol 13 2006 491 500